Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions.

Military Medical Research·2026
Same author

Antibiotic surveillance: an action-oriented integrated approach.

Wellcome open research·2026
Same author

Visnagin Attenuates Thioacetamide-Induced Liver Injury and Fibrosis Through the Modulation of TLR4-Mediated Inflammation and Downregulation of TGF-β/α-SMA-Driven Fibrogenesis.

Journal of applied toxicology : JAT·2026
Same author

Nootkatone mitigates LPS-induced acute lung injury by modulating the NF-κB and Nrf2 pathways in mice.

Frontiers in veterinary science·2025
Same author

Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge.

American journal of physiology. Gastrointestinal and liver physiology·2025
Same author

Gut microbiome-specific nanoparticle-based therapeutics for liver diseases.

World journal of gastroenterology·2025

Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
07:13

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

1.6K

Silver nanoparticle based multifunctional approach for combating COVID-19.

Prince Allawadhi1, Vishakha Singh2, Amit Khurana3,4,5

  • 1Department of Pharmacy, Vaish Institute of Pharmaceutical Education and Research (VIPER), Pandit Bhagwat Dayal Sharma University of Health Sciences (Pt. B. D. S. UHS), Rohtak - 124001, Haryana, India.

Sensors International
|November 12, 2021
PubMed
Summary

Silver nanoparticles (AgNPs) show potential as an antiviral agent against COVID-19 by inducing cell death. Their size and shape influence biological activity, suggesting AgNPs could aid in managing the pandemic.

Keywords:
AntimicrobialAntiviral activityCOVID-19Cytokine stormSilver nanoparticles

More Related Videos

Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
11:19

Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties

Published on: May 10, 2018

10.4K
Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.0K

Related Experiment Videos

Last Updated: Oct 13, 2025

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
07:13

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

1.6K
Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
11:19

Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties

Published on: May 10, 2018

10.4K
Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.0K

Area of Science:

  • Nanotechnology
  • Biomedical Science
  • Infectious Disease Research

Background:

  • COVID-19 poses a significant global health challenge.
  • Silver nanoparticles (AgNPs) possess known antimicrobial and antiviral properties.
  • AgNPs are explored for their potential to combat viral infections.

Purpose of the Study:

  • To evaluate the potential of silver nanoparticles (AgNPs) as an antiviral agent against COVID-19.
  • To highlight the current status and applications of AgNPs in managing the COVID-19 pandemic.

Main Methods:

  • Review of existing literature on AgNPs and their antiviral mechanisms.
  • Analysis of how AgNP properties (size, shape) affect biological interactions.
  • Exploration of AgNP-induced free radical generation and reactive oxygen species (ROS) pathways.

Main Results:

  • AgNPs demonstrate potent antiviral capabilities against various viruses.
  • AgNPs can induce apoptosis via free radical and ROS generation, inhibiting viral replication.
  • The efficacy of AgNPs is dependent on their specific size and shape.

Conclusions:

  • Silver nanoparticles (AgNPs) represent a promising therapeutic strategy for COVID-19 management.
  • Further research into tailored AgNP formulations could optimize antiviral efficacy.
  • AgNPs offer a potential avenue for bolstering global healthcare responses to viral pandemics.